{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:00:51Z","timestamp":1790283651681,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    [\n                    <jats:sup>11<\/jats:sup>\n                    C]Methionine ([\n                    <jats:sup>11<\/jats:sup>\n                    C]MET) PET provides high sensitivity to localize corticotroph pituitary neuroendocrine tumors (PitNETs) in\n                    <jats:italic>de novo<\/jats:italic>\n                    Cushing\u2019s disease but remains inconclusive in up to 20% of cases. Current PET protocols rely on late acquisitions (20\u201340\u00a0min post-injection). Since other endocrine tumors present earlier peak tracer uptake, corticotroph PitNETs might also exhibit early differential amino acid uptake, compared to the normal pituitary gland. This exploratory study based on data derived from a previously registered prospective multicenter cohort study (ClinicalTrials.gov identifier: NCT03346954) included 15 patients with pathologically confirmed corticotroph PitNETs accurately localized using MRI. Kinetic analysis showed rapid early uptake in PitNETs and normal pituitary gland, followed by a significant decline over time, with consistently higher uptake in PitNETs (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05), but no statistically significant difference in temporal uptake pattern (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.09). Early uptake slope and peak uptake were significantly higher in PitNETs compared to normal gland (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01), with moderate-to-high discriminative performance (area under the curve 0.78; 95%CI 0.60\u20130.94 and 0.86; 95%CI 0.69\u20130.98, respectively). Time-to-peak showed no statistically significant discriminative value. These findings suggest that kinetic parameters of [\u00b9\u00b9C]MET PET, particularly early slope and peak uptake, may provide complementary information to static PET for PitNET characterization.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-39219-7","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T08:06:50Z","timestamp":1772179610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["[\u00b9\u00b9C]Methionine PET uptake kinetics in corticotroph pituitary neuroendocrine tumors"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5877-2159","authenticated-orcid":false,"given":"Anthime","family":"Flaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Patt\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Criton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Costes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Levigoureux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Haesebaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Vasiljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"IMPEC Collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Briet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Castinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Cristante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Drui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Germain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Illouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Sonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Tauveron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Merida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lancelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucien","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Rode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Bertholon-Gregoire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Lapras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Jouanneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bournaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Raverot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"39219_CR1","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s40618-022-01754-1","volume":"45","author":"G Giuffrida","year":"2022","unstructured":"Giuffrida, G. et al. Global cushing\u2019s disease epidemiology: a systematic review and meta-analysis of observational studies. J. Endocrinol. Invest. 45, 1235\u20131246 (2022).","journal-title":"J. Endocrinol. Invest."},{"key":"39219_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa, S. L., Mete, O., Perry, A. & Osamura, R. Y. Overview of the 2022 WHO classification of pituitary tumors. Endocr. Pathol. 33, 6\u201326 (2022).","journal-title":"Endocr. Pathol."},{"key":"39219_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu, M. et al. Consensus on diagnosis and management of cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol. 9, 847\u2013875 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"39219_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3174\/ajnr.A7789","volume":"44","author":"M Castle-Kirszbaum","year":"2023","unstructured":"Castle-Kirszbaum, M. et al. MRI for Cushing disease: A systematic review. AJNR Am. J. Neuroradiol. 44, 311\u2013316 (2023).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"39219_CR5","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.2967\/jnumed.124.269392","volume":"66","author":"A Flaus","year":"2025","unstructured":"Flaus, A. et al. Prospective multicenter evaluation of [11\u00a0C]Methionine PET\/MRI sensitivity compared with MRI for localizing small pituitary neuroendocrine tumor or pituitary adenoma in Cushing disease. J. Nucl. Med. 66, 1575\u20131580 (2025).","journal-title":"J. Nucl. Med."},{"key":"39219_CR6","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00259-018-4207-9","volume":"46","author":"I Law","year":"2019","unstructured":"Law, I. et al. Joint EANM\/EANO\/RANO practice guidelines\/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0. Eur. J. Nucl. Med. Mol. Imaging. 46, 540\u2013557 (2019).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"39219_CR7","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2967\/jnumed.118.225599","volume":"60","author":"WAM Broos","year":"2019","unstructured":"Broos, W. A. M., Wondergem, M., van der Zant, F. M. & Knol, R. J. J. Dual-Time-Point 18F-Fluorocholine PET\/CT in parathyroid imaging. J. Nucl. Med. 60, 1605\u20131610 (2019).","journal-title":"J. Nucl. Med."},{"key":"39219_CR8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/MNM.0000000000001217","volume":"41","author":"WAM Broos","year":"2020","unstructured":"Broos, W. A. M., Wondergem, M., van der Zant, F. M., Schaper, N. C. & Knol, R. J. J. Dynamic 18F-fluorocholine PET\/CT for parathyroid imaging in patients with primary hyperparathyroidism. Nucl. Med. Commun. 41, 776 (2020).","journal-title":"Nucl. Med. Commun."},{"key":"39219_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1148\/radiology.177.1.2399335","volume":"177","author":"Y Miki","year":"1990","unstructured":"Miki, Y. et al. Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging. Radiology 177, 35\u201338 (1990).","journal-title":"Radiology"},{"key":"39219_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1148\/radiology.178.2.1987606","volume":"178","author":"Y Sakamoto","year":"1991","unstructured":"Sakamoto, Y., Takahashi, M., Korogi, Y., Bussaka, H. & Ushio, Y. Normal and abnormal pituitary glands: gadopentetate dimeglumine-enhanced MR imaging. Radiology 178, 441\u2013445 (1991).","journal-title":"Radiology"},{"key":"39219_CR11","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.2967\/jnumed.111.092726","volume":"52","author":"G Delso","year":"2011","unstructured":"Delso, G. et al. Performance measurements of the Siemens mMR integrated Whole-Body PET\/MR scanner. J. Nucl. Med. 52, 1914\u20131922 (2011).","journal-title":"J. Nucl. Med."},{"key":"39219_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1055\/s-2007-980192","volume":"39","author":"T Friedman","year":"2007","unstructured":"Friedman, T., Zuckerbraun, E., Lee, M., Kabil, M. & Shahinian, H. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild cushing\u2019s syndrome and should be part of the initial workup. Horm. Metab. Res. 39, 451\u2013456 (2007).","journal-title":"Horm. Metab. Res."},{"key":"39219_CR13","doi-asserted-by":"publisher","first-page":"14694","DOI":"10.1038\/s41598-020-71628-0","volume":"10","author":"Z Liu","year":"2020","unstructured":"Liu, Z. et al. High positive predictive value of the combined pituitary dynamic enhanced MRI and high-dose dexamethasone suppression tests in the diagnosis of cushing\u2019s disease bypassing bilateral inferior petrosal sinus sampling. Sci. Rep. 10, 14694 (2020).","journal-title":"Sci. Rep."},{"key":"39219_CR14","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1007\/s00259-024-06728-4","volume":"51","author":"D Van Weehaeghe","year":"2024","unstructured":"Van Weehaeghe, D. et al. EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours. Eur. J. Nucl. Med. Mol. Imaging. 51, 2367\u20132370 (2024).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"39219_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1053\/j.semnuclmed.2023.02.005","volume":"53","author":"D Gillett","year":"2023","unstructured":"Gillett, D. et al. Molecular imaging of pituitary tumors. Semin Nucl. Med. 53, 530\u2013538 (2023).","journal-title":"Semin Nucl. Med."},{"key":"39219_CR16","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3171\/2023.5.JNS23179","volume":"139","author":"A Ishida","year":"2023","unstructured":"Ishida, A. et al. Clinical decision-making based on 11\u00a0C-methionine PET in recurrent cushing\u2019s disease with equivocal MRI findings. J. Neurosurg. 139, 1671\u20131680 (2023).","journal-title":"J. Neurosurg."},{"key":"39219_CR17","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1210\/clinem\/dgaf047","volume":"110","author":"RM Furnica","year":"2025","unstructured":"Furnica, R. M. et al. Diagnostic value of 11\u00a0C-Methionine PET-CT imaging in persistent or recurrent Cushing disease after surgery. J. Clin. Endocrinol. Metab. 110, 2845\u20132852 (2025).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39219-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39219-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39219-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:59:52Z","timestamp":1781636392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39219-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39219"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39219-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8854"}}